GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anti-Microbial Savior BioteQ Co Ltd (ROCO:6864) » Definitions » EPS (Diluted)

Anti-Microbialvior BioteQ Co (ROCO:6864) EPS (Diluted) : NT$-2.07 (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Anti-Microbialvior BioteQ Co EPS (Diluted)?

Anti-Microbialvior BioteQ Co's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was NT$-1.25. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-2.07.

Anti-Microbialvior BioteQ Co's EPS (Basic) for the six months ended in Dec. 2023 was NT$-1.25. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-2.07.

Anti-Microbialvior BioteQ Co's EPS without NRI for the six months ended in Dec. 2023 was NT$-1.25. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-2.07.

During the past 3 years, the average EPS without NRIGrowth Rate was -8.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 6 years, Anti-Microbialvior BioteQ Co's highest 3-Year average EPS without NRI Growth Rate was -4.00% per year. The lowest was -8.10% per year. And the median was -6.05% per year.


Anti-Microbialvior BioteQ Co EPS (Diluted) Historical Data

The historical data trend for Anti-Microbialvior BioteQ Co's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anti-Microbialvior BioteQ Co EPS (Diluted) Chart

Anti-Microbialvior BioteQ Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
Get a 7-Day Free Trial -1.13 -1.64 -1.19 -1.27 -2.07

Anti-Microbialvior BioteQ Co Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only -0.60 -0.50 -0.77 -0.82 -1.25

Competitive Comparison of Anti-Microbialvior BioteQ Co's EPS (Diluted)

For the Biotechnology subindustry, Anti-Microbialvior BioteQ Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Anti-Microbialvior BioteQ Co's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Anti-Microbialvior BioteQ Co's PE Ratio distribution charts can be found below:

* The bar in red indicates where Anti-Microbialvior BioteQ Co's PE Ratio falls into.



Anti-Microbialvior BioteQ Co EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Anti-Microbialvior BioteQ Co's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-51.782-0)/26.535
=-1.95

Anti-Microbialvior BioteQ Co's Diluted EPS for the quarter that ended in Dec. 2023 is calculated as

Diluted EPS (Q: Dec. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-31.246-0)/27.676
=-1.13

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-2.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Anti-Microbialvior BioteQ Co  (ROCO:6864) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Anti-Microbialvior BioteQ Co EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Anti-Microbialvior BioteQ Co's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Anti-Microbialvior BioteQ Co (ROCO:6864) Business Description

Traded in Other Exchanges
N/A
Address
Sec.1, Huandong Road, 1 Floor, No. 2, Ln. 31, Xinshi District, Tainan, TWN, 741
Anti-Microbial Savior BioteQ Co Ltd is engaged in drug research and development as well as development and technology patenting of medical fungi.

Anti-Microbialvior BioteQ Co (ROCO:6864) Headlines

No Headlines